Literature DB >> 19095845

A comparison of the molecular bases for N-methyl-D-aspartate-receptor inhibition versus immobilizing activities of volatile aromatic anesthetics.

Jason C Sewell1, Douglas E Raines, Edmond I Eger, Michael J Laster, John W Sear.   

Abstract

BACKGROUND: Aromatic anesthetics exhibit a wide range of N-methyl-d-aspartate (NMDA) receptor inhibitory potencies and immobilizing activities. We sought to characterize the molecular basis of NMDA receptor inhibition using comparative molecular field analysis (CoMFA), and compare the results to those from an equivalent model for immobilizing activity.
METHODS: Published potency data for 14 compounds were supplemented with new values for 2 additional agents. The anesthetics were divided into a training set (n = 12) used to formulate the activity models and a test set (n = 4) used to independently assess the models' predictive capability. The anesthetic structures were geometry optimized using ab initio quantum mechanics and aligned by field-fit minimization to provide the best correlation between the steric and electrostatic fields of the molecules and one or more lead structures. Orientations that yielded CoMFA models with the greatest predictive capability (assessed by leave-one-out cross-validation) were retained.
RESULTS: The final CoMFA model for the inhibition of NR1/NR2B NMDA receptors explained 99.3% of the variance in the observed activities of the 12 training set agents (F(2,)(9) = 661.5, P < 0.0001). The model effectively predicted inhibitory potency for the training set (cross-validated r(2)(CV) = 0.944) and 4 excluded test set compounds (predictive r(2)(Pred) = 0.966). The equivalent model for immobility in response to noxious stimuli explained 98.0% of the variance in the observed activities for the training set (F(2,)(9) = 219.2, P < 0.0001) and exhibited adequate predictive capability for both the training set (r(2)(CV) = 0.872) and test set (r(2)(Pred) = 0.926) agents. Comparison of pharmacophoric maps showed that several key steric and electrostatic regions were common to both activity models, but differences were observed in the relative importance of these key regions with respect to the two aspects of anesthetic activity.
CONCLUSIONS: The similarities in the pharmacophoric maps are consistent with NMDA receptors contributing part of the immobilizing activity of volatile aromatic anesthetics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19095845      PMCID: PMC3606081          DOI: 10.1213/ane.0b013e31818de158

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  16 in total

1.  Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol.

Authors:  T Yamakura; R A Harris
Journal:  Anesthesiology       Date:  2000-10       Impact factor: 7.892

Review 2.  The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications.

Authors:  Jennifer M Loftis; Aaron Janowsky
Journal:  Pharmacol Ther       Date:  2003-01       Impact factor: 12.310

3.  Derivation of preliminary three-dimensional pharmacophores for nonhalogenated volatile anesthetics.

Authors:  Jason C Sewell; John W Sear
Journal:  Anesth Analg       Date:  2004-09       Impact factor: 5.108

4.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

Authors:  R D Cramer; D E Patterson; J D Bunce
Journal:  J Am Chem Soc       Date:  1988-08-01       Impact factor: 15.419

5.  Do N-methyl-D-aspartate receptors mediate the capacity of inhaled anesthetics to suppress the temporal summation that contributes to minimum alveolar concentration?

Authors:  Robert C Dutton; Michael J Laster; Yilei Xing; James M Sonner; Douglas E Raines; Ken Solt; Edmond I Eger
Journal:  Anesth Analg       Date:  2006-05       Impact factor: 5.108

6.  Volatile aromatic anesthetics variably impact human gamma-aminobutyric acid type A receptor function.

Authors:  Elizabeth W Kelly; Ken Solt; Douglas E Raines
Journal:  Anesth Analg       Date:  2007-11       Impact factor: 5.108

7.  Determinants of volatile general anesthetic potency: a preliminary three-dimensional pharmacophore for halogenated anesthetics.

Authors:  Jason C Sewell; John W Sear
Journal:  Anesth Analg       Date:  2006-03       Impact factor: 5.108

8.  A new procedure for improving the predictiveness of CoMFA models and its application to a set of dihydrofolate reductase inhibitors.

Authors:  R T Kroemer; P Hecht
Journal:  J Comput Aided Mol Des       Date:  1995-10       Impact factor: 3.686

9.  Contrasting synaptic actions of the inhalational general anesthetics isoflurane and xenon.

Authors:  S L de Sousa; R Dickinson; W R Lieb; N P Franks
Journal:  Anesthesiology       Date:  2000-04       Impact factor: 7.892

10.  The N-methyl-D-aspartate receptor inhibitory potencies of aromatic inhaled drugs of abuse: evidence for modulation by cation-pi interactions.

Authors:  Douglas E Raines; Fredrick Gioia; Robert J Claycomb; Renna J Stevens
Journal:  J Pharmacol Exp Ther       Date:  2004-05-27       Impact factor: 4.030

View more
  1 in total

1.  γ-Aminobutyric Acid Type A Receptor Modulation by Etomidate Analogs.

Authors:  Ervin Pejo; Peter Santer; Lei Wang; Philip Dershwitz; S Shaukat Husain; Douglas E Raines
Journal:  Anesthesiology       Date:  2016-03       Impact factor: 7.892

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.